Sight Sciences, Inc., (SGHT) News

Sight Sciences, Inc., (SGHT): $8.63

-0.34 (-3.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter SGHT News Items

SGHT News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SGHT News Highlights

  • SGHT's 30 day story count now stands at 7.
  • Over the past 29 days, the trend for SGHT's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • TRIP are the most mentioned tickers in articles about SGHT.

Latest SGHT News From Around the Web

Below are the latest news stories about SIGHT SCIENCES INC that investors may wish to consider to help them evaluate SGHT as an investment opportunity.

Owning 30% shares,institutional owners seem interested in Sight Sciences, Inc. (NASDAQ:SGHT),

Key Insights Significantly high institutional ownership implies Sight Sciences' stock price is sensitive to their...

Yahoo | March 23, 2023

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2022 Earnings Call Transcript

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2022 Earnings Call Transcript March 13, 2023 Operator: Hello, and welcome to Sight Sciences Fourth Quarter 2022 Earnings Results. At this time, all participants are in listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. I would now like to hand the conference over to Trip Taylor […]

Yahoo | March 14, 2023

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates

Sight Sciences, Inc. (SGHT) delivered earnings and revenue surprises of 16.67% and 0.80%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | March 13, 2023

Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results

MENLO PARK, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today reported financial results for the fourth quarter and year ended December 31, 2022 and issued financial guidance for the year ending December 31, 2023. Recent Financial Highlights Generated 2022 total revenue of $71.3 million, an increase

Yahoo | March 13, 2023

Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System

The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures Ergo-Series of the OMNI® Surgical System by Sight Sciences, Inc. The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures MENLO PARK, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technolo

Yahoo | March 9, 2023

Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023

MENLO PARK, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, after the market close on Monday, March 13, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m

Yahoo | February 23, 2023

Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference

MENLO PARK, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced plans to present at the upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference in New York, NY. Sight Sciences’ management is scheduled to participate in a fireside chat on Wednesday, March 1, 2023, at 3:30pm ET. Interested parties may access a liv

Yahoo | February 22, 2023

3 Prime Healthcare Takeover Targets

Investors can win big when they invest in healthcare stocks that are likely takeover targets. CRISPR Therapeutics (NASDAQ: CRSP), BioMarin Pharmaceutical (NASDAQ: BMRN), and Sight Sciences (NASDAQ: SGHT) all stand out as potential healthcare stocks that are excellent takeover targets this year. CRISPR Therapeutics is one of the likeliest takeover targets among biotech stocks.

Yahoo | February 14, 2023

Sight Sciences Announces 1,000th TearCare® Customer Installation

Over 1,000 Professional Eye Care Practices Have integrated the TearCare® System to Treat Root Cause of Dry Eye Disease due to Meibomian Gland Dysfunction (MGD)MENLO PARK, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announced today the 1,000th installation of its TearCare® System. The TearCare® System i

Yahoo | January 26, 2023

Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results

Company Also Announces CFO TransitionMENLO PARK, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announces several Company updates. Preliminary Revenue ResultsThe Company is announcing preliminary unaudited financial results for the fourth quarter and year ended December 31, 2022. Fourth quarter 202

Yahoo | January 9, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6204 seconds.